| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50742-401-02 | 50742-401 | HUMAN PRESCRIPTION DRUG | Irinotecan Hydrochloride | Irinotecan Hydrochloride | INJECTION | INTRAVENOUS | 20170605 | N/A | ANDA | ANDA206935 | Ingenus Pharmaceuticals, LLC | IRINOTECAN HYDROCHLORIDE | 40 mg/2mL | 1 VIAL, GLASS in 1 CARTON (50742-401-02) / 2 mL in 1 VIAL, GLASS |
| 50742-402-05 | 50742-402 | HUMAN PRESCRIPTION DRUG | Irinotecan Hydrochloride | Irinotecan Hydrochloride | INJECTION | INTRAVENOUS | 20170605 | N/A | ANDA | ANDA206935 | Ingenus Pharmaceuticals, LLC | IRINOTECAN HYDROCHLORIDE | 100 mg/5mL | 1 VIAL, GLASS in 1 CARTON (50742-402-05) / 5 mL in 1 VIAL, GLASS |